Recurrent respiratory papillomatosis

A rare disease characterized by PAPILLOMA growth in the respiratory tract. The tumors may vary in size, grow very quickly, and often grow back even when removed. They are caused by HUMAN PAPILLOMAVIRUS 6 and HUMAN PAPILLOMAVIRUS 11 infections.

Also Known As:

Juvenile laryngeal papilloma; Juvenile-onset recurrent respiratory papillomatosis; Laryngeal papilloma, recurrent; Respiratory papillomatosis

Infections: 526564
- Virus Diseases: 41777
  - DNA Virus Infections: 139
    - Papillomavirus Infections: 4871
      - Recurrent respiratory papillomatosis: 444
  - Tumor Virus Infections: 39
    - Papillomavirus Infections: 4871
      - Recurrent respiratory papillomatosis: 444
  - Viral Sexually Transmitted Diseases: 13
    - Papillomavirus Infections: 4871
      - Recurrent respiratory papillomatosis: 444
- Communicable Diseases: 25324
  - Sexually Transmitted Diseases: 11501
    - Viral Sexually Transmitted Diseases: 13
      - Papillomavirus Infections: 4871
        Recurrent respiratory papillomatosis: 444
- Respiratory Tract Infections: 14082
  - Recurrent respiratory papillomatosis: 444
- Sexually Transmitted Diseases: 11501
  - Viral Sexually Transmitted Diseases: 13
    - Papillomavirus Infections: 4871
      - Recurrent respiratory papillomatosis: 444
Respiratory Tract Diseases: 6015
- Respiratory Tract Infections: 14082
  - Recurrent respiratory papillomatosis: 444
Urogenital Diseases: 126
- Genital Diseases: 114
  - Sexually Transmitted Diseases: 11501
    - Viral Sexually Transmitted Diseases: 13
      - Papillomavirus Infections: 4871
        Recurrent respiratory papillomatosis: 444
Signs and Symptoms Pathological Conditions
- Pathologic Processes: 10023
  - Disease Attributes: 18
    - Communicable Diseases: 25324
      - Sexually Transmitted Diseases: 11501
        Viral Sexually Transmitted Diseases: 13
        Papillomavirus Infections: 4871
        Recurrent respiratory papillomatosis: 444

Avigdor M Ronn Selected Research

Avigdor M Ronn Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure